These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum protein binding of diphenylhydantoin in man. II. Interaction with sodium valproate in epileptic patients. Gatti G, Lecchini S, Frigo GM, Visintini D, Calzetti S, Lombardi M, Cattaino G. Farmaco Prat; 1979 Jan; 34(1):46-8. PubMed ID: 378689 [No Abstract] [Full Text] [Related]
4. Valproate may lower serum-phenytoin. Bardy A, Hari R, Lehtovaara R, Majuri H. Lancet; 1976 Dec 11; 2(7998):1297-8. PubMed ID: 63764 [No Abstract] [Full Text] [Related]
9. Valproate may lower serum-phenytoin. Bardy A, Hari R, Lehtovaara R, Majuri H. Lancet; 1977 Jun 11; 1(8024):1256-7. PubMed ID: 68349 [No Abstract] [Full Text] [Related]
12. [Daily fluctuations of plasma diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate]. Pisani F, Di Perri R. Acta Neurol (Napoli); 1981 Feb 11; 3(1):61-3. PubMed ID: 6787844 [No Abstract] [Full Text] [Related]
18. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy. Shakir RA, Johnson RH, Lambie DG, Melville ID, Nanda RN. Epilepsia; 1981 Feb 11; 22(1):27-33. PubMed ID: 6781888 [Abstract] [Full Text] [Related]